| abstract |
The present disclosure is generally directed to compositions that include antibodies, e.g. , monoclonal, chimeric, humanized antibodies, antibody fragments, etc. , that specifically bind on or more epitopes within a Sortilin protein, e.g ., human Sortilin or a mammalian Sortilin, and use of such compostions in preventing, reducing risk, or treating an individual in need thereof. |